One of the biggest challenges for biopharmaceutical companies of rare and orphan disease patient populations is optimizing disease management in a way that enhances the patient journey and improves outcomes.
Source : https://hitconsultant.net/2021/01/08/patient-first-strategy-specialty-rx-pharmacists/
Date : January 8, 2021 at 03:41PM
Tag(s) : #eSANTE ENG
